Literature DB >> 11256890

Apoptosis and airway inflammation in asthma.

A M Vignola1, G Chiappara, R Gagliardo, M Gjomarkaj, A Merendino, L Siena, J Bousquet, G Bonsignore.   

Abstract

Asthma is a disease characterized by a chronic inflammation of the airways and by structural alterations of bronchial tissues, often referred to as airway remodelling. The development of chronic airway inflammation in asthma depends upon the continuous recruitment of inflammatory cells from the bloodstream towards the bronchial mucosa and by their subsequent activation. It is however increasingly accepted that mechanisms involved in the regulation of the survival and apoptosis of inflammatory cells may play a central role in the persistent inflammatory process characterizing this disease. Increased cellular recruitment and activation, enhanced cell survival and cell:cell interactions are therefore the key steps in the development of chronic airway inflammation in asthma, and represent the major causes for tissue damge, repair and remodelling.

Entities:  

Mesh:

Year:  2000        PMID: 11256890     DOI: 10.1023/a:1009661406440

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  14 in total

Review 1.  Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets.

Authors:  Vikas Mishra; Jaspreet Banga; Patricia Silveyra
Journal:  Pharmacol Ther       Date:  2017-08-23       Impact factor: 12.310

2.  Trade-offs between cancer and other diseases: do they exist and influence longevity?

Authors:  Svetlana V Ukraintseva; Konstantin G Arbeev; Igor Akushevich; Alexander Kulminski; Liubov Arbeeva; Irina Culminskaya; Lucy Akushevich; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2010-08       Impact factor: 4.663

3.  Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction.

Authors:  Gabriel Moran; Virginia A Buechner-Maxwell; Hugo Folch; Claudio Henriquez; Juan S Galecio; Barbara Perez; Cristian Carrasco; Miguel Barria
Journal:  Vet Res Commun       Date:  2011-05-19       Impact factor: 2.459

4.  Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis.

Authors:  Lena Uller; Cecilia Ahlström Emanuelsson; Morgan Andersson; Jonas S Erjefält; Lennart Greiff; Carl G Persson
Journal:  Respir Res       Date:  2010-05-09

5.  Glutathione peroxidase-2 protects from allergen-induced airway inflammation in mice.

Authors:  A M Dittrich; H-A Meyer; M Krokowski; D Quarcoo; B Ahrens; S M Kube; M Witzenrath; R S Esworthy; F-F Chu; E Hamelmann
Journal:  Eur Respir J       Date:  2009-11-06       Impact factor: 16.671

6.  Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.

Authors:  Feifei Xu; Shaoqing Yu; Mali Qin; Yong Mao; Ling Jin; Na Che; Shuangxi Liu; Rongming Ge
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

Review 7.  T lymphocyte apoptosis in asthma.

Authors:  O Potapinska; U Demkow
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

8.  Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma.

Authors:  Xiaolin Diao; Juan Wang; Hong Zhu; Bei He
Journal:  BMC Pulm Med       Date:  2016-11-15       Impact factor: 3.317

9.  Hydrogen-rich saline attenuates eosinophil activation in a guinea pig model of allergic rhinitis via reducing oxidative stress.

Authors:  Shaoqing Yu; Chuanliang Zhao; Na Che; Lin Jing; Rongming Ge
Journal:  J Inflamm (Lond)       Date:  2017-01-13       Impact factor: 4.981

10.  Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.

Authors:  Janina Grzegorczyk; Marek L Kowalski; Anna Pilat; Jolanta Iwaszkiewicz
Journal:  Mediators Inflamm       Date:  2002-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.